Incidence and prevalence of adverse drug reactions;Incidence et prevalence des effets indesirables des medicaments

Presse Medicale

Volumn 29, Issue 2, 2000, Pages 111-114

  Haramburu, Francoise ^a,c   Pouyanne, P ^a   Imbs, J L ^d   Blayac, J P ^b   Begaud B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Hopital Saint Charles   (France)

^c HÔPITAL PELLEGRIN   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; HOSPITALIZATION; INCIDENCE; MORBIDITY; MORTALITY; PREVALENCE; REVIEW; AUSTRALIA; COMPARATIVE STUDY; DRUG MONITORING; EUROPE; FRANCE; GENERAL PRACTICE; HOSPITAL; HUMAN; LEBANON; META ANALYSIS; PROSPECTIVE STUDY; UNITED STATES;

DRUG;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AUSTRALIA; DRUG MONITORING; EUROPE; FAMILY PRACTICE; FRANCE; HOSPITALS; HUMANS; INCIDENCE; LEBANON; META-ANALYSIS; PHARMACEUTICAL PREPARATIONS; PREVALENCE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0034700779     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Anonymous. International reporting of adverse drug reactions. Final report of CIOMS Working group. Council for International Organizations of Medical Sciences, Geneva, 1990.
2. Allain H, Chenant-Breton J, Beneton C et al. Conséquences dermatologiques indésirables des médicaments. Résultats d'une enquête de pharmacovigilance. Ann Med Interne 1983 ; 134:530-6.
3. Trunet P, Le Gall JR, Lhoste F et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980 ; 244:2617-20.
4. Rostin M, Pascaud A, Larque D, Sorbette F, Carles P, Montastruc JL. Enquète intensive de pharmacovigilance dans un service d'admission médicale. Rev Med Interne 1987 ; 8:173-9.
5. Moore N, Lecointre D, Noblet C, Vlabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998 ; 45:301-8.
6. Lagnaoui R. Le risque iatrogène médicamenteux à l'hôpital : incidence, prévalence et coût direct. Etude prospective dans un service de médecine interne du C.H.U. de Bordeaux. Th. Pharm. Univ. Victor Segalen Bordeaux 2, 1997, no 80.
7. Le Goaster A. Les effets indésirables médicamenteux à l'hôpital : incidence et notification. Enquête menée au C.H.U. de Bordeaux de janvier à mars 1994. Comparaison à la notification spontanée. Th. Pharm. Univ. Reims, 1995, 30 janvier 1995.
8. Queneau P, Chabot JM, Rajaana H, Boisser C, Grandmottet P. latrogénie observée en milieu hospitalier. I. A propos de 109 cas colligés à partir d'une enquête transversale de l'APNET. Bull Acad Natl Med 1992 ; 176:511-26.
9. Hallas J, Jensen KB, Grodum E, Darrsbo N, Gram LF. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991 ; 26:174-80.
10. Hallas J, Davidson O, Grodum E, Damsbo N, Gram LF. Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration 1992 ; 59:30-4.
11. Hallas J, Gram LF, Grodum E et al. Drug-related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992 ; 33:61-8.
12. Schoenemann J, Munker KH, Enayati-KashaniS. Ünerwunschte Arzneimittelwirkungen in der Klinik. Dtsch Med Wochensch 1998 : 123:448-52.
13. Major S, Badr S, Bahlawan L, Hassan C, Khogaoghlanian T, Khalil R et al. Drug-related hospitalization in a tertiary teaching center in Lebanon: incidence, associations and relation to self-medicating behavior. Clin Pharmacol Ther 1998 ; 64:450-61.
14. Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994 ; 19:341-7.
15. Munoz MJ, Ayani I, Rodriguez-Sasiain JM, Gutierrez G, Aguirre C. Monitorizacion en un servicio de urgencias de reacciones adverses causadas por medicamentos en ninos y adultos. Med Clin (Barc) 1998 ; 111:92-8.
16. McKenney JM, Harrson WL. Drug-related hospital admissions. Am J Hosp Pharm 1976 ; 33:792-5.
17. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1996 ; 274:29-34.
18. Martinez-Mir I, Garcia Lopez M, Palop V, Ferrer JM, Estan L et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996 ; 42:319-24.
19. Wu FL, Yang CL, Shen W, Chen CY. Adverse drug reactions in a medical ward. J Formos Med Assoc 1996 ; 95:241-6.
20. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27:832-40.
21. Lazarou J, Pomeranz BH, Corey P. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279:1200-5.
22. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998 ; 168:405-8.
23. Imbs JL, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac JP, Bégaud B et le réseau des Centres régionaux de pharmacovigilance. latrogénie médicamenteuse : estimation de sa prévalence dans les hôpitaux publics français. Therapie 1999; 52:21-7.
24. th Annual meeting of the European Society of Pharmacovigilance, Budapest, September 27-28, 1998.
25. Moride Y, Haramburu F, Alvarez-Requejo A, Bégaud B. Under-reporting of adverse drug reactions in general practice ? Br J Clin Pharmacol 1997; 43:177-81.
26. Lacoste-Roussillon C. Etude de l'incidence des effets indésirables médicamenteux graves en médecine générale. Mémoire pour le Diplôme d'Etudes Approfondies Epidémiologie et Intervention en Santé publique, Université Victor Segalen, Institut de Santé publique, d'Epidémiologie et de Développement, Bordeaux, septembre 1998.
27. Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol 1998 ; 46:505-11.
28. Kubota K, Kubota N, Pearce GL, Prescott P, Mann RD. Signalling drug-induced rash wth 36 drugs recently marketed in the Unted Kingdom and studied by Prescription Event Monitoring. Int J Clin Pharmacol Ther 1995 ; 33:219-25.